Placebo DPI

DRUG13 trials

Sponsors

Amphastar Pharmaceuticals, Inc., GlaxoSmithKline, Celon Pharma SA, Chiesi Farmaceutici S.p.A., University of Tennessee Graduate School of Medicine

Conditions

AsthmaBipolar DepressionBronchospasmCOPD (Chronic Obstructive Pulmonary Disease)Chronic Obstructive Pulmonary DiseaseChronic Obstructive Pulmonary Disease (COPD)Healthy VolunteersMajor Depressive Disorder

Phase 1

QTc Study GSK573719+GW642444

CompletedNCT01521377

GlaxoSmithKlinePulmonary Disease, Chronic Obstructive

Start: 2011-12-19End: 2012-06-05Updated: 2017-06-12

Safety and Pharmacokinetic Study of Inhaled Esketamine in Healthy Volunteers

CompletedNCT03407872

Celon Pharma SAHealthy Volunteers

Start: 2017-12-09End: 2018-06-19Updated: 2018-07-12

Phase 2

Escalating and Cumulative-Dose Study of Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety of A006

CompletedNCT01189396

Amphastar Pharmaceuticals, Inc.Asthma, Bronchospasm, Chronic Obstructive Pulmonary Disease (COPD)

Start: 2010-07-31End: 2011-01-31Updated: 2017-07-02

Albuterol DPI (A006) Clinical Study-B2: Efficacy, Dose-Ranging and Initial Safety Evaluation

CompletedNCT01581177

Amphastar Pharmaceuticals, Inc.Asthma

Start: 2012-04-30End: 2012-08-31Updated: 2017-05-19

Albuterol DPI (A006) Clinical Study-B3:Efficacy, Dose-ranging and Safety Evaluation

CompletedNCT02210806

Amphastar Pharmaceuticals, Inc.Asthma

Start: 2014-07-31End: 2014-10-31Updated: 2017-04-19

A Study to Investigate the Efficacy, Safety, and Tolerability of Repeat Doses of Inhaled GSK2269557 in Adults With Persistent, Uncontrolled Asthma

CompletedNCT02567708

GlaxoSmithKlinePulmonary Disease, Chronic Obstructive

Start: 2015-10-01End: 2016-09-28Updated: 2018-08-01

Efficacy of Fixed Combination of Beclomethasone Dipropionate (BDP) + Formoterol Fumarate (FF) + Glycopyrronium Bromide (GB) (CHF 5993)Administered Via Dry Powder Inhaler (DPI) in Chronic Obstructive Pulmonary Disease (COPD)

CompletedNCT03590379

Chiesi Farmaceutici S.p.A.Chronic Obstructive Pulmonary Disease

Start: 2018-06-15End: 2019-03-06Updated: 2021-04-12

Efficacy, Safety and Pharmacokinetic Study of Inhaled Esketamine in Treatment-resistant Depression

CompletedNCT03965858

Celon Pharma SAMajor Depressive Disorder

Start: 2019-02-25End: 2020-04-24Updated: 2020-04-28

Efficacy, Safety and Pharmacokinetic Study of Inhaled Esketamine in Treatment-resistant Bipolar Depression

CompletedNCT03965871

Celon Pharma SABipolar Depression

Start: 2019-03-28End: 2021-02-19Updated: 2021-03-19

Phase 4

A Study to Evaluate the Effect of Umeclidinium (UMEC) as Combination Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

CompletedNCT02257372

GlaxoSmithKlinePulmonary Disease, Chronic Obstructive

Start: 2014-09-30End: 2015-03-24Updated: 2017-08-17

A Study to Evaluate the Effect of the Combination of Umeclidinium (UMEC) and Vilanterol (VI) on Exercise Endurance Time (EET) in Participants With Chronic Obstructive Pulmonary Disease (COPD)

CompletedNCT02275052

GlaxoSmithKlinePulmonary Disease, Chronic Obstructive

Start: 2015-01-23End: 2016-06-02Updated: 2018-08-16

An Open-label Study to Evaluate Correct Use and Ease of Use of the ELLIPTA DPI in Pediatric Subjects With Asthma

CompletedNCT03478657

GlaxoSmithKlineAsthma

Start: 2018-06-18End: 2018-12-07Updated: 2021-03-26

Compare the Effects of Nebulizer Versus Inhaler Based Therapy for COPD Using Long-acting Bronchodilators

RecruitingNCT07133880

University of Tennessee Graduate School of MedicineCOPD (Chronic Obstructive Pulmonary Disease)

Start: 2023-12-05End: 2025-12-01Target: 72Updated: 2025-08-27

Related Papers

Comparison of Dry-Powder Inhaler and Pressurized Metered-Dose Inhaler Formulations of Extrafine Beclomethasone Dipropionate/Formoterol Fumarate/Glycopyrronium in Patients with COPD: The TRI-D Randomized Controlled Trial.

2021-01-1416 citations

The evaluation of the correct use and ease‐of use of the ELLIPTA DPI in children with asthma

Pediatric Pulmonology2020-10-301 citations

The effect of umeclidinium added to inhaled corticosteroid/long-acting β2-agonist in patients with symptomatic COPD: a randomised, double-blind, parallel-group study.

2016-06-2314 citations

P124 A randomised, parallel-group study to evaluate the effect of umeclidinium added to inhaled corticosteroid/long-acting beta-agonist combination therapy in subjects with chronic obstructive pulmonary disease: Abstract P124 Table 1

Thorax2015-11-121 citations